Advertisement
Embed Coronary Stents - Infographic on your site
Advertisement
Limiting the use of drug-eluting stents to a selected group of patients saves money and do not increase death or heart attack risk, reveals analysis published in Circulation: Journal of the American Heart Association.
The selective use of drug-eluting stents, which began in 2007, is saving the U.S. healthcare system about $400 million annually, researchers said.
Advertisement
